We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 18,265

Don't forget about GINA

  • Miller & Martin LLP
  • -
  • USA
  • -
  • May 17 2013

In the midst of trying to keep straight all employer responsibilities, obligations, and pitfalls under the ADA and the FMLA, as well as a plethora of

HIPAA's new normal: the Omnibus HIPAA rulemaking

  • Schwabe Williamson & Wyatt
  • -
  • USA
  • -
  • May 16 2013

On January 25, 2013, the Office of Civil Rights of the federal Department of Health and Human Services published the rules implementing the Health

Employee notices about PPACA insurance exchanges - guidance issued

  • Vedder Price PC
  • -
  • USA
  • -
  • May 16 2013

One of the 2013 action items for employers under the Patient Protection and Affordable Care Act (PPACA) is the production and distribution of a

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Payment transparency: what Sunshine means for your practice

  • LeClairRyan
  • -
  • USA
  • -
  • May 16 2013

Passed as part of the Patient Protection and Affordable Care Act of 2010, the Physician Payment Sunshine Act (also known as the "PPSA" or the

Biotech receives $32.5 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Celator Pharmaceuticals, Inc., a Princeton, New Jersey-based company that develops cancer therapies, has raised $32.5 million in the final closing of

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

News Bytes - May 16, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The National Institutes of Health (NIH) Office of Biotechnology Activities proposes revising the "NIH Guidelines for Research Involving Recombinant

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

IRS, Treasury Department issue proposed rules governing minimum value, affordability, and wellness programs

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • May 16 2013

A key policy goal of the Patient Protection and Affordable Care Act (the "Act") is the expansion of health insurance coverage to all Americans. The